Documentos relacionados

1. Application of thromboelastography to predict the severity of bleeding after chimeric antigen receptor (CAR)-T cell therapy in patients with hematological malignancy.
2. The utility of thromboelastometry in prophylactic platelet transfusion for hematological malignancies.
3. Thromboelastography (TEG®) compared with total platelet count in thrombocytopenia haematological malignancy patients with bleeding: a pilot observational study.
4. Developing a classification of hematologic neoplasms in the era of precision medicine.
5. CREST: clinical bleeding and risk evaluation in hematology-oncology patients: a systematic review and meta-analysis of thromboelastography's role.
6. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
7. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies.
8. Benefits of Thromboelastography and Thrombin Generation Assay for Bleeding Prediction in Patients With Thrombocytopenia or Hematologic Malignancies.
9. Outcomes of Jehovah's Witnesses with hematological malignancies treated without transfusions - single center experience.
10. Prophylactic platelet transfusion response in critically ill patients: a prospective multicentre observational study.